|
Richard W. Peluso, Ph.D., Vice President, Process Development
Richard Peluso has been with Targeted Genetics since 2000. Before joining Targeted Genetics he worked for Genovo, a private gene therapy company near Philadelphia. Dr. Peluso worked for two years prior to Genovo for Quality Biotech/ViroMed, a contract biosafety testing company. Prior to that he held academic positions at several medical schools, the most recent the Mount Sinai School of Medicine in New York, where he was an associate professor and ran an academic research lab. Richard obtained a PhD from The Rockefeller University in New York in Virology with Professors Purnell Choppin and Robert Lamb. Richard serves on the editorial board of Virology and Human Gene Therapy. | 